Plain-English translation of NCT07207148 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Researchers at Northwestern University want to understand how ocrelizumab and medications work together in people with multiple sclerosis. This study will track your symptoms, disability, weight, mood, and quality of life over about 18 months to see if these two medications together help slow MS progression or improve how you feel.
Ocrelizumab is already used to treat MS, and medications are gaining attention for potential benefits in MS. Doctors want to learn whether combining these two treatments might be more helpful than ocrelizumab alone—and whether this combination is safe and well-tolerated.
You likely qualify if…
You likely don't qualify if…
The study has two parts with slightly different requirements. In both, you'll fill out surveys about your symptoms, medications, weight, mood, and exercise roughly every 4 weeks for 72 weeks (about 18 months). You'll have video check-ins every 6 months with the research team. If you're in the part that allows remote participation, you can do everything from home; if you're in the other part, you'll visit the clinic in person for some assessments including walking tests and possibly blood work.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United States